ifosfamide,polatuzumab vedotin,etoposide,carboplatin
roche
['etoposide', 'carboplatin', 'ifosfa', ' pola ']
#ash22 polar-ice, n=41, 34% del, 17% dhl, 11 % failed to collect stem cells, 61% went on to autopbsct, end of salvage orr 80%, cr 56%, higher rates in relapsed pts. 
MD